Profil
Robert Janssen worked at the Centers for Disease Control & Prevention from 2000 to 2008 as Director-HIV & AIDS Prevention Division.
From 2008 to 2010, worked at Gilead Sciences, Inc. as Vice President-Medical Affairs.
From 2010 to 2026, worked at Dynavax Technologies Corp., serving as Chief Medical Officer & VP-Clinical Development from 2015 to 2018.
Education includes undergraduate studies at Stanford University and a doctorate from the University of Southern California.
Anciens postes connus de Robert Janssen
| Sociétés | Poste | Fin |
|---|---|---|
| DYNAVAX TECHNOLOGIES CORPORATION | Directeur Technique/Scientifique/R&D | 02/03/2026 |
| GILEAD SCIENCES, INC. | Directeur Technique/Scientifique/R&D | 01/01/2010 |
Centers for Disease Control & Prevention
Centers for Disease Control & Prevention General GovernmentGovernment Operates as a government health center | Corporate Officer/Principal | 01/01/2008 |
Formation de Robert Janssen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Gilead Sciences, Inc.
Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Dynavax Technologies Corp.
Dynavax Technologies Corp. BiotechnologyHealth Technology Develops and commercializes novel products to prevent and treat infectious diseases | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Southern California
University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Centers for Disease Control & Prevention
Centers for Disease Control & Prevention General GovernmentGovernment Operates as a government health center | Government |
















